Table 16Summary of ablative therapy underlying liver disease characteristics: nonrandomized comparative studies

Study
Rating
Group
N
Cirrhosis%HBV%HCV%NAFLD%Alcohol%
Chok et al. 200653
Poor
TACE
40
NR78NRNRNR
RFA
51
NR82NRNRNR

Abbreviations: HBV = hepatitis B virus; HCV = hepatitis C virus; N = number of patients; NAFLD = nonalcoholic fatty liver disease; NR = not reported; RFA = radiofrequency ablation; TACE = transarterial chemoembolization

From: Results

Cover of Local Therapies for Unresectable Primary Hepatocellular Carcinoma
Local Therapies for Unresectable Primary Hepatocellular Carcinoma [Internet].
Comparative Effectiveness Reviews, No. 114.
Belinson S, Yang Y, Chopra R, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.